• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与C9orf72相关的肌萎缩侧索硬化症和额颞叶痴呆症的发展

The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders.

作者信息

Yang Qijie, Jiao Bin, Shen Lu

机构信息

Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.

National Clinical Research Center for Geriatric Disorders, Central South University, Changsha, China.

出版信息

Front Genet. 2020 Sep 2;11:562758. doi: 10.3389/fgene.2020.562758. eCollection 2020.

DOI:10.3389/fgene.2020.562758
PMID:32983232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7492664/
Abstract

The expanded GGGGCC hexanucleotide repeat in the non-coding region of the gene is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). There are three main disease mechanisms: loss of function of C9ORF72 protein, gain of function from the accumulation of sense and antisense (GGGGCC)n in RNA, and from the production of toxic dipeptides repeat proteins (DPRs) by non-AUG initiated translation. While many of the downstream mechanisms have been identified, the specific pathogenic pathway is still unclear. In this article, we provide an overview on the currently available literature and propose several hypotheses: (1) The pathogenesis of -associated ALS/FTD, which cannot be explained by a single mechanism, involves a dual mechanism of both loss and gain of function. (2) The loss of function and gain of function can cause TDP-43 aggregation and damage nucleocytoplasmic transport. (3) Neurodegeneration can be caused by an accumulation of toxic substances in neurons themselves. In addition, we suggest that microglia may cause neurodegeneration by releasing inflammatory factors to neurons. Finally, we summarize several of the most promising treatment strategies.

摘要

基因非编码区中扩展的GGGGCC六核苷酸重复序列是肌萎缩侧索硬化症(ALS)和额颞叶痴呆(FTD)最常见的遗传病因。存在三种主要的疾病机制:C9ORF72蛋白功能丧失、RNA中正义和反义(GGGGCC)n积累导致的功能获得,以及非AUG起始翻译产生有毒二肽重复蛋白(DPRs)。虽然已经确定了许多下游机制,但具体的致病途径仍不清楚。在本文中,我们概述了当前可用的文献并提出了几种假设:(1)与相关的ALS/FTD的发病机制不能用单一机制解释,涉及功能丧失和功能获得的双重机制。(2)功能丧失和功能获得可导致TDP-43聚集并损害核质运输。(3)神经退行性变可能由神经元自身有毒物质的积累引起。此外,我们认为小胶质细胞可能通过向神经元释放炎症因子而导致神经退行性变。最后,我们总结了几种最有前景的治疗策略。

相似文献

1
The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders.与C9orf72相关的肌萎缩侧索硬化症和额颞叶痴呆症的发展
Front Genet. 2020 Sep 2;11:562758. doi: 10.3389/fgene.2020.562758. eCollection 2020.
2
Molecular Mechanisms of Neurodegeneration Related to Hexanucleotide Repeat Expansion.与六核苷酸重复序列扩增相关的神经退行性变的分子机制
Behav Neurol. 2019 Jan 15;2019:2909168. doi: 10.1155/2019/2909168. eCollection 2019.
3
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.已有新发现:额颞叶痴呆/肌萎缩侧索硬化中C9orf72突变的新机制。
Brain Res. 2016 Sep 15;1647:19-29. doi: 10.1016/j.brainres.2016.04.004. Epub 2016 Apr 6.
4
Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.与C9orf72基因六核苷酸重复扩增相关的肌萎缩侧索硬化症/额颞叶痴呆的致病决定因素及机制
Neurosci Lett. 2017 Jan 1;636:16-26. doi: 10.1016/j.neulet.2016.09.007. Epub 2016 Sep 13.
5
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.C9orf72 相关肌萎缩侧索硬化/额颞叶痴呆的疾病机制与潜在治疗策略的研究进展。
Ageing Res Rev. 2020 Dec;64:101172. doi: 10.1016/j.arr.2020.101172. Epub 2020 Sep 22.
6
The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD.二肽重复序列在与C9ORF72相关的肌萎缩侧索硬化症-额颞叶痴呆中的作用。
Front Mol Neurosci. 2017 Feb 13;10:35. doi: 10.3389/fnmol.2017.00035. eCollection 2017.
7
Mechanisms of Immune Activation by Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.肌萎缩侧索硬化症和额颞叶痴呆中扩增导致免疫激活的机制
Front Neurosci. 2019 Dec 10;13:1298. doi: 10.3389/fnins.2019.01298. eCollection 2019.
8
Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.对9号染色体开放阅读框72(C9orf72)重复扩增致病机制的见解。
J Neurochem. 2016 Aug;138 Suppl 1:145-62. doi: 10.1111/jnc.13623. Epub 2016 Jun 15.
9
Non-coding RNA in -related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction.与肌萎缩侧索硬化症和额颞叶痴呆相关的非编码RNA:功能障碍的完美风暴。
Noncoding RNA Res. 2018 Sep 10;3(4):178-187. doi: 10.1016/j.ncrna.2018.09.001. eCollection 2018 Dec.
10
Modeling -Related Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in .在……中模拟相关的额颞叶痴呆和肌萎缩侧索硬化症
Front Cell Neurosci. 2021 Oct 21;15:770937. doi: 10.3389/fncel.2021.770937. eCollection 2021.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Therapeutic Approaches for C9ORF72-Related ALS: Current Strategies and Future Horizons.C9ORF72相关肌萎缩侧索硬化症的治疗方法:当前策略与未来展望
Int J Mol Sci. 2025 Jun 28;26(13):6268. doi: 10.3390/ijms26136268.
3
Inhibition of PolyGA Dipeptide Repeat Protein Aggregation by Nucleic Acid Aptamers in C9 Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Models.

本文引用的文献

1
C9orf72 suppresses systemic and neural inflammation induced by gut bacteria.C9orf72 抑制肠道细菌引起的全身和神经炎症。
Nature. 2020 Jun;582(7810):89-94. doi: 10.1038/s41586-020-2288-7. Epub 2020 May 13.
2
Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72.C9ORF72 功能降低会加剧 ALS/FTD 致病重复扩展引起的毒性获得。
Nat Neurosci. 2020 May;23(5):615-624. doi: 10.1038/s41593-020-0619-5. Epub 2020 Apr 13.
3
Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders.
在C9型肌萎缩侧索硬化症-额颞叶痴呆模型中核酸适配体对聚甘氨酰胺二肽重复蛋白聚集的抑制作用
Mol Neurobiol. 2025 May 24. doi: 10.1007/s12035-025-05075-1.
4
Targeting Gene Pathogenesis for Amyotrophic Lateral Sclerosis.针对肌萎缩侧索硬化症的基因发病机制
Int J Mol Sci. 2025 Apr 30;26(9):4276. doi: 10.3390/ijms26094276.
5
Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances.了解肌萎缩侧索硬化症:病理生理学、诊断和治疗进展。
Int J Mol Sci. 2024 Sep 15;25(18):9966. doi: 10.3390/ijms25189966.
6
C9orf72-Associated Dipeptide Repeat Expansions Perturb ER-Golgi Vesicular Trafficking, Inducing Golgi Fragmentation and ER Stress, in ALS/FTD.C9orf72 相关二肽重复扩展扰乱 ER-Golgi 囊泡运输,导致 ALS/FTD 中的高尔基体碎片化和内质网应激。
Mol Neurobiol. 2024 Dec;61(12):10318-10338. doi: 10.1007/s12035-024-04187-4. Epub 2024 May 9.
7
Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis.TDP - 43功能丧失导致肌萎缩侧索硬化症中的基因组不稳定。
Front Neurosci. 2023 Oct 2;17:1251228. doi: 10.3389/fnins.2023.1251228. eCollection 2023.
8
Insight into Tetramolecular DNA G-Quadruplexes Associated with ALS and FTLD: Cation Interactions and Formation of Higher-Ordered Structure.解析与 ALS 和额颞叶痴呆相关的四聚体 DNA G-四链体:阳离子相互作用和更高阶结构的形成。
Int J Mol Sci. 2023 Aug 30;24(17):13437. doi: 10.3390/ijms241713437.
9
RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis.RNA结合蛋白作为肌萎缩侧索硬化症和多发性硬化症中神经退行性变和炎症的共同基础。
Front Mol Neurosci. 2023 Jul 4;16:1193636. doi: 10.3389/fnmol.2023.1193636. eCollection 2023.
10
Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity.C9orf72表达降低会加剧患者诱导多能干细胞衍生的运动神经元中的多聚GR毒性,而一种I型蛋白质精氨酸甲基转移酶抑制剂可降低这种毒性。
Front Cell Neurosci. 2023 Apr 17;17:1134090. doi: 10.3389/fncel.2023.1134090. eCollection 2023.
C9ORF72 缺失导致的自噬减少与 G4C2 重复扩增疾病中二肽重复蛋白毒性协同作用。
EMBO J. 2020 Feb 17;39(4):e100574. doi: 10.15252/embj.2018100574. Epub 2020 Jan 13.
4
Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72.全基因组合成致死 CRISPR 筛选鉴定 FIS1 为 ALS 相关 C9ORF72 的遗传相互作用因子。
Brain Res. 2020 Feb 1;1728:146601. doi: 10.1016/j.brainres.2019.146601. Epub 2019 Dec 13.
5
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.用于亨廷顿病治疗的突变 HTT 的等位基因选择性转录抑制。
Nat Med. 2019 Jul;25(7):1131-1142. doi: 10.1038/s41591-019-0478-3. Epub 2019 Jul 1.
6
C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo.C9ORF72-ALS/FTD 相关多聚(GR)结合 Atp5a1 并在体内损害线粒体功能。
Nat Neurosci. 2019 Jun;22(6):851-862. doi: 10.1038/s41593-019-0397-0. Epub 2019 May 13.
7
Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity.无意义介导的 mRNA 降解的激活可防止 C9orf72 二肽重复神经毒性。
Brain. 2019 May 1;142(5):1349-1364. doi: 10.1093/brain/awz070.
8
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.基于RNA干扰的基因疗法靶向C9orf72相关肌萎缩侧索硬化症和/或额颞叶痴呆中的RNA介导毒性
Mol Ther Nucleic Acids. 2019 Jun 7;16:26-37. doi: 10.1016/j.omtn.2019.02.001. Epub 2019 Feb 11.
9
Heterochromatin anomalies and double-stranded RNA accumulation underlie poly(PR) toxicity.异染色质异常和双链 RNA 积累是聚(PR)毒性的基础。
Science. 2019 Feb 15;363(6428). doi: 10.1126/science.aav2606.
10
The Hairpin Form of r(GC) in c9ALS/FTD Is Repeat-Associated Non-ATG Translated and a Target for Bioactive Small Molecules.c9ALS/FTD 中 r(GC)的发夹结构是重复相关的非 ATG 翻译产物,也是生物活性小分子的作用靶点。
Cell Chem Biol. 2019 Feb 21;26(2):179-190.e12. doi: 10.1016/j.chembiol.2018.10.018. Epub 2018 Nov 29.